LY6D, LY6E, LY6H, and LY6K have increased mRNA expression in tumor tissues of ovarian, colorectal, gastric, breast, lung, bladder, brain, cervical, esophageal, head and neck, and pancreatic cancer compared to adjacent normal tissues. Here, LY6D is linked to familial pancreatic carcinoma.